Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Pediatric Nephrology
Published in: Pediatric Nephrology 7/2018

01-07-2018 | Obituary

Professor Gavin C. Arneil (1923–2018)

Authors: Heather Maxwell, David A. Hughes, T James Beattie

Published in: Pediatric Nephrology | Issue 7/2018

Login to get access

Excerpt

Gavin Cranston Arneil: Born March 7, 1923; Died January 21, 2018 …
Metadata
Title
Professor Gavin C. Arneil (1923–2018)
Authors
Heather Maxwell
David A. Hughes
T James Beattie
Publication date
01-07-2018
Publisher
Springer Berlin Heidelberg
Published in
Pediatric Nephrology / Issue 7/2018
Print ISSN: 0931-041X
Electronic ISSN: 1432-198X
DOI
https://doi.org/10.1007/s00467-018-3956-9

Other articles of this Issue 7/2018

Pediatric Nephrology 7/2018 Go to the issue

Original Article

The first hour refill index: a promising marker of volume overload in children and young adults on chronic hemodialysis

Original Article

Describing pediatric acute kidney injury in children admitted from the emergency department

Educational Review

Clinical management of nocturnal enuresis

Educational Review

Vitamin and trace element deficiencies in the pediatric dialysis patient

Brief Report

Cyclosporine A responsive congenital nephrotic syndrome with single heterozygous variants in NPHS1, NPHS2, and PLCE1

Brief Report

Hyperphosphatemic tumoral calcinosis caused by FGF23 compound heterozygous mutations: what are the therapeutic options for a better control of phosphatemia?